• Home
  • News
    • People moves
    • Africa
    • Asia
    • Australia
    • Canada
    • Caribbean
    • Domicile
    • Europe
    • Latin America
    • North America
    • Middle East
    • US
    • US
    • UK
  • Products
    • Funds
    • Pensions
    • Platforms
    • Insurance
    • Investments
    • Private Banking
    • Citizenship
    • Mortgages
    • Taxation
  • Fintech
  • Regulation
  • In Depth
  • Special Reports
  • Video
  • Directory
  • Advertise with us
  • Events
  • Middle East Hub
  • Newsletters
  • Follow us
    • Twitter
    • LinkedIn
    • Newsletters
  • Advertise with us
  • Events
    • Upcoming events
      View all events
  • Middle East Hub
International Investment
International Investment

Sponsored by

Sharing Alpha
  • Home
  • News
  • Products
  • Fintech
  • Regulation
  • In Depth
  • Special Reports
  • Video
  • Directory
  • Investments

UK healthcare scam fraudsters jailed

UK healthcare scam fraudsters jailed
  • Eugene Costello
  • 21 December 2017
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Send to  

Four fraudsters who conned their largely elderly and vulnerable victims out of £1.4m in a worthless investment scheme have been jailed and confiscation orders passed to seize their assets, the UK regulator has announced.

Samrat Bhandari, whom the judge described as “the prime mover” in the sale of shares had his sentencing adjourned.

Related articles

  • FCA action sees four guilty in £1.4m Dubai medical investment scheme
  • UK boiler room scammers ordered to repay victims
  • FCA action brings prison sentence for fraudster in £1.4m investment scam
  • Extra jail time for fraudster after FCA acts on unpaid fine

He offered to arrange funds to reimburse investors in this period. However, this offer was subsequently withdrawn and Bhandari will be sentenced in late January, and will remain in custody until he is sentenced.

Dr Muhammad Aleem Mirza was sentenced to 15 months’ imprisonment.

He was disqualified as a director for eight years. The judge said that his dealings had “brought about his professional ruin” and that he had put his own ambitions and pride before his responsibilities as the director of a company.

Both Mirza and Bhandari were convicted on 30 November, following a trial at Southwark Crown Court that lasted 49 days.

Michael Moore was sentenced to 15 months’ imprisonment and his brother Paul Moore to 9 months’ imprisonment; both had pleaded guilty at an earlier hearing.

The judge said that Michael Moore knew exactly what he was doing from the outset of his involvement in the scheme.

Michael and Paul Moore are already serving seven years’ imprisonment resulting from their involvement in a separate investment scheme.

They will serve their sentences consecutively, meaning they will serve total sentences of 8 years 3 months and 7 years 9 months respectively. They had both previously been disqualified from holding the position of director for ten years.

There is some prospect of investors recovering their money and at yesterday’s hearing the FCA began confiscation proceedings against each defendant, “with a view to recovering from each the benefit they gained from their criminal conduct”, the FCA said in a statement.

“In due course, the FCA will invite the Court to order that sums confiscated from the defendants are used to compensate the victims of their crimes,” the statement added.

‘Wholly misleading’ investment picture

The FCA said that between 2009 and 2014, each of the four defendants played an instrumental role in the systematic and prolonged misleading of investors, many of whom were vulnerable, retired individuals, through the creation of a wholly misleading impression as to the value and prospects of Symbiosis Healthcare Plc.

Mirza set up Symbiosis as a company purporting to offer “healthcare solutions” and Bhandari, as director of William Albert Securities Ltd, acted as corporate adviser to Symbiosis and organised the selling of Symbiosis shares.

Both were responsible for publishing misleading statements and exaggerated promotional material which was designed to fool investors.

Additionally, said the FCA, investors were cold-called by brokers, including the Moore brothers, and mis-sold shares in Symbiosis.

Despite promises to investors of large profits, and extravagant claims about the operation and expansion of a network of medical clinics in Dubai and elsewhere, in reality the shares in the company were effectively worthless.

In total, over 300 investors lost just over £1.4 million through the scheme.

 

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Send to  
  • Topics
  • Investments
  • Regulation
  • UK
  • FCA

More on Investments

FCA claws back £291,000 from investment scheme fraudster

  • Regulation
  • 27 November 2019
Hong Kong rules that trustees are protected under anti-Bartlett clauses

  • Trusts
  • 27 November 2019
Citigroup slammed with record £44m fine for reporting failures

  • Banking
  • 27 November 2019
Australian watchdog slaps 5-year ban on former Linchpin director

  • Regulation
  • 27 November 2019
UK country head at Franklin Templeton Martyn Gilbey
Franklin Templeton takes Embark stake amid UK retirement expansion plans

  • Investments
  • 26 November 2019
Back to Top

Most read

EXCLUSIVE: deVere agrees sale of South Africa business
EXCLUSIVE: deVere agrees sale of South Africa business
DeVere to close Barcelona office
DeVere to close Barcelona office
US FATCA crackdown pushing demand for tax advice
US FATCA crackdown pushing demand for tax advice
Kuwait to ban diabetic expats
Kuwait to ban diabetic expats
UAE is most prosperous Arab nation and Saudi Arabia jumps 14 spots
UAE is most prosperous Arab nation and Saudi Arabia jumps 14 spots
  • Contact Us
  • Marketing solutions
  • About Incisive Media
  • Terms and conditions
  • Policies
  • Careers
  • Twitter
  • LinkedIn
  • Newsletters

© Incisive Business Media (IP) Limited, Published by Incisive Business Media Limited, New London House, 172 Drury Lane, London WC2B 5QR, registered in England and Wales with company registration numbers 09177174 & 09178013

Digital publisher of the year
Digital publisher of the year 2010, 2013, 2016 & 2017